Clinical trials
Completed Fibrosis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 8 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 8 |
| 2013 | 7 |
| 2014 | 14 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 97 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 15 |
| Hospices Civils de Lyon | 10 |
| Gilead Sciences | 6 |
| Centre Hospitalier Universitaire de Besancon | 4 |
| University Hospital, Tours | 4 |
| Centre Hospitalier Universitaire, Amiens | 3 |
| University Hospital, Toulouse | 3 |
| AbbVie | 2 |
| IHU Strasbourg | 2 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 97 |
| Liver Cirrhosis | 10 |
| Carcinoma, Hepatocellular | 9 |
| Hepatitis C | 9 |
| Hypertension, Portal | 8 |
| Non-alcoholic Fatty Liver Disease | 8 |
| Digestive System Diseases | 4 |
| Fatty Liver | 4 |
| Hepatitis | 4 |
| Liver Diseases | 4 |
Trials
Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.